These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18221037)

  • 1. Innovative cancer treatments that augment radiotherapy or chemo-therapy by the use of immunotherapy or gene therapy.
    Lucas R; Keisari Y
    Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):201-8. PubMed ID: 18221037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bio-immunotherapy for cancer in experimental studies and clinical application: current status and future challenges.
    Shen RN; Lu L; Kaiser HE; Broxmeyer HE
    In Vivo; 1994; 8(5):643-52. PubMed ID: 7727711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of cytokines and chemokines in the cancer immunotherapy.
    Amedei A; Prisco D; D' Elios MM
    Recent Pat Anticancer Drug Discov; 2013 May; 8(2):126-42. PubMed ID: 22894642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adapting conventional cancer treatment for immunotherapy.
    Qiao J; Liu Z; Fu YX
    J Mol Med (Berl); 2016 May; 94(5):489-95. PubMed ID: 26910191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The need for improvement of the treatment of advanced and metastatic cervical cancer, the rationale for combined chemo-immunotherapy.
    van Meir H; Kenter GG; Burggraaf J; Kroep JR; Welters MJ; Melief CJ; van der Burg SH; van Poelgeest MI
    Anticancer Agents Med Chem; 2014 Feb; 14(2):190-203. PubMed ID: 24237223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
    Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity?
    Wirsdörfer F; de Leve S; Jendrossek V
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy.
    Shahabi V; Postow MA; Tuck D; Wolchok JD
    Am J Clin Oncol; 2015 Feb; 38(1):90-7. PubMed ID: 25616204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune modulation by ionizing radiation and its implications for cancer immunotherapy.
    Friedman EJ
    Curr Pharm Des; 2002; 8(19):1765-80. PubMed ID: 12171547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatment modalities in radiation therapy.
    Holland J
    J Intraven Nurs; 2001; 24(2):95-101. PubMed ID: 11836839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antitumor activity of immune strategies combined with radiation.
    Sharp HJ; Wansley EK; Garnett CT; Chakraborty M; Camphausen K; Schlom J; Hodge JW
    Front Biosci; 2007 Sep; 12():4900-10. PubMed ID: 17569618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current perspectives in immunotherapy.
    Lillehei KO; Liu Y; Kong Q
    Ann Thorac Surg; 1999 Sep; 68(3 Suppl):S28-33. PubMed ID: 10505988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing tumor immune response through combination of radiation and immunotherapy.
    El Chediak A; Shamseddine A; Bodgi L; Obeid JP; Geara F; Zeidan YH
    Med Oncol; 2017 Aug; 34(9):165. PubMed ID: 28828581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Booming cancer immunotherapy fighting tumors.
    Li D; Wang W
    Sci China Life Sci; 2017 Dec; 60(12):1445-1449. PubMed ID: 29170888
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-15: new kid on the block for antitumor combination therapy.
    Van den Bergh JM; Van Tendeloo VF; Smits EL
    Cytokine Growth Factor Rev; 2015 Feb; 26(1):15-24. PubMed ID: 25306466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation therapy and immunotherapy: what is the optimal timing or sequencing?
    Aliru ML; Schoenhals JE; Venkatesulu BP; Anderson CC; Barsoumian HB; Younes AI; K Mahadevan LS; Soeung M; Aziz KE; Welsh JW; Krishnan S
    Immunotherapy; 2018 Feb; 10(4):299-316. PubMed ID: 29421979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy.
    Wargo JA; Reuben A; Cooper ZA; Oh KS; Sullivan RJ
    Semin Oncol; 2015 Aug; 42(4):601-16. PubMed ID: 26320064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interplay of immunotherapy and chemotherapy: harnessing potential synergies.
    Emens LA; Middleton G
    Cancer Immunol Res; 2015 May; 3(5):436-43. PubMed ID: 25941355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.